I-123 Biomarker Committee: Difference between revisions

Revision as of 20:49, 16 November 2018

Co-chairs: John Dickson, PhD; John Seibyl, MD

Secretary: Julie Lisiecki

Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases

Revision as of 19:07, 9 August 2018 view source Jlisiecki (talk \| contribs) Bureaucrats, Administrators 7,000 edits m →Recent Meetings/Call Summaries ← Older edit		Revision as of 20:49, 16 November 2018 view source Jlisiecki (talk \| contribs) Bureaucrats, Administrators 7,000 edits m →Reference Materials Newer edit →
Line 15:		Line 15:

	==Reference Materials==		==Reference Materials==

			*[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf \| QIBA SPECT I-123 Biomarker Committee Presentation]] ''John Seibyl, MD''